Edwards Lifesciences Corporation Common Stock vs Lumentum — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Lumentum trades at $1,079.28 (market cap $100.64B). The key difference: Lumentum is far larger — about 2× Edwards Lifesciences Corporation Common Stock's market cap, and Edwards Lifesciences Corporation Common Stock is more actively traded (3,508,027 versus 3,383,346). Which is the better fit depends on your goals.
| EW | LITE | |
|---|---|---|
Market Cap | $49.44B | $100.64B |
Volume | 3,508,027 | 3,383,346 |
Sector | Health | Technology |
52-Week High | $95.18 | $1.13K |
52-Week Low | $72.65 | $149.61 |
Enterprise Value | $45.90B | $99.58B |
Typical Hold Time | — | 4 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →